Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Debt / NOTE 1.250% 5/1
-
Unit price / market price
-
$1.08
-
Total 13F principal
-
$378,710,174
-
Principal change
-
-$101,516,861
-
Total reported value
-
$408,842,645
-
Number of holders
-
44
-
Value change
-
-$98,743,328
-
Number of buys
-
19
-
Number of sells
-
11
Institutional Holders of BIOMARIN PHARMACEUTICAL INC - NOTE 1.250% 5/1 as of Q4 2022
As of 31 Dec 2022 BIOMARIN PHARMACEUTICAL INC - NOTE 1.250% 5/1 had 44 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of $378,710,174 principal (par value or face value) of the bond of the company.
Largest 10 bondholders included Voya Investment Management LLC, MACKAY SHIELDS LLC, ADVENT CAPITAL MANAGEMENT /DE/, BRAIDWELL LP, Thrivent Financial for Lutherans, STATE STREET CORP, DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main, Invesco Ltd., Sonora Investment Management Group, LLC, and AVIVA PLC.
This table shows 44 bond principal holders of the security as of 31 Dec 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.